Specifies that prior authorizations for drugs prescribed to manage a chronic condition shall not be revoked or modified within 13 months

SB 811 prevents insurance companies from revoking or changing prior authorizations for medications managing chronic conditions within 13 months of initial approval. This directly affects patients with long-term health conditions (like diabetes or heart disease) who rely on consistent medication access. The key provision mandates that once an insurer approves a drug for a chronic condition, they cannot alter that approval for at least 13 months without justification. The bill aims to reduce disruptive changes to treatment plans by creating a stable period for patients and providers.